共 50 条
Mast cells as therapeutic target in cancer
被引:60
|作者:
Ribatti, Domenico
[1
,2
]
机构:
[1] Univ Bari, Sch Med, Dept Basic Med Sci Neurosci & Sensory Organs, Policlin Piazza G Cesare 11, I-70124 Bari, Italy
[2] Natl Canc Inst Giovanni Paolo II, Bari, Italy
关键词:
Anticancer agents;
Mast cells;
Tryptase;
Tumor growth;
Tyrosine kinase inhibitors;
TYROSINE KINASE INHIBITOR;
BONE-MARROW ANGIOGENESIS;
CHRONIC LYMPHOCYTIC-LEUKEMIA;
ENDOTHELIAL GROWTH-FACTOR;
HUMAN-BREAST-CANCER;
CHORIOALLANTOIC MEMBRANE;
SYSTEMIC MASTOCYTOSIS;
TUMOR ANGIOGENESIS;
TRYPTASE ACTIVITY;
PULMONARY ADENOCARCINOMA;
D O I:
10.1016/j.ejphar.2015.02.056
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Mast cells promote tumorigenesis and tumor progression, and have functions that favor the host. Increased mast cell number correlates with a poor prognosis in several human tumors. In different vascular tumors, as well as a number of hematological and solid tumors, mast cell accumulation correlate with increased neovascularization, tumor aggressiveness, and metastatic spread. Mast cells might act as a new target for the adjuvant treatment of tumors through the selective inhibition of angiogenesis, tissue remodeling and tumor -promoting molecules, permitting the secretion of cytotoxic cytokines and preventing mast cell -mediated immune suppression. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:152 / 157
页数:6
相关论文